GSK Announces US FDA Approval of Benlysta (belimumab) for Pediatric Patients with Active Lupus Nephritis

Benlysta is now the first and only biologic approved for adults and children who have lupus or lupus nephritis London UK 27 July 2022 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news